Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Mackall Website

Crystal L. Mackall, M.D.

Selected Publications

1)  Orentas RJ, Nordlund J, He J, Sindiri S, Mackall C, Fry TJ, Khan J.
Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison.
Front Oncol. 4: 134, 2014.
[Journal]
2)  Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL.
Current concepts in the diagnosis and management of cytokine release syndrome.
Blood. 124: 188-95, 2014.
[Journal]
3)  Highfill SL, Cui Y, Giles AJ, Smith JP, Zhang H, Morse E, Kaplan RN, Mackall CL.
Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.
Sci Transl Med. 6: 237ra67, 2014.
[Journal]
4)  Mackall CL.
Introduction to the series of reviews on "Antibody Derivatives as New Therapeutics for Hematologic Malignancies".
Blood. 123: 2283-4, 2014.
[Journal]
5)  Prieto DA, Johann DJ, Wei BR, Ye X, Chan KC, Nissley DV, Simpson RM, Citrin DE, Mackall CL, Linehan WM, Blonder J.
Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Biomark Med. 8: 269-86, 2014.
[Journal]
6)  Duncan BB, Highfill SL, Qin H, Bouchkouj N, Larabee S, Zhao P, Woznica I, Liu Y, Li Y, Wu W, Lai JH, Jones B, Mackall CL, Bachovchin WW, Fry TJ.
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.
J. Immunother. 36: 400-11, 2013.
[Journal]
7)  Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ.
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood. 121: 1165-74, 2013.
[Journal]
8)  van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM.
Enhancing immune reconstitution: from bench to bedside.
Biol. Blood Marrow Transplant. 19: S79-83, 2013.
[Journal]
9)  Zhang H, Maric I, Diprima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL.
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.
Blood. 122: 1105-13, 2013.
[Journal]
10)  Brehm C, Huenecke S, Pfirrmann V, Rossig C, Mackall CL, Bollard CM, Gottschalk S, Schlegel PG, Klingebiel T, Bader P.
Highlights of the third international conference on immunotherapy in pediatric oncology.
Pediatr Hematol Oncol. 30: 349-66, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/19/2014.